EPFL partners with Stanford to advance life science research

Catalyze4Life, an Innovation Initiative of EPFL has partnered with the similar SPARK program at Stanford University to further advance its mission of fostering innovative research and technologies in the life sciences. Catalyze4Life is an initiative spearheaded by EPFL's School of Life Sciences. Established in 2017, Catalyze4Life is designed to increase the maturity of academic discoveries towards applications in the life science space. For example, in 2018 Catalyze4Life succeeded in obtaining an Orphan Drug Designation for a new amyotrophic lateral sclerosis drug based on gene therapy that was in the preclinical stages of development at EPFL. Catalyze4Life has now partnered with the SPARK program of Stanford University. SPARK was established by Professor Daria Mochly-Rosen , in 2006 for advancing new biomedical research discoveries into promising new treatments for patients. It provides top-tier mentoring and education, and a cost-effective model to generate proof of concept by using industry standards.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login

Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience